[1] 徐成波,廖斌,齐彦,等.伴全身弥漫性皮肤红斑的非特指型外周T细胞淋巴瘤一例并文献复习[J].白血病·淋巴瘤,2021,30(7):426-428. [2] Cadranel J,Wislez M,Antoine M.Primary pulmonary lymphoma[J].Eur Respir,2002,20(3):750-762. [3] De Figueiredo RH,Parreira BS,Canao PA,Cardoso L,et al.Peripheral T-Cell Lymphoma,Not Otherwise Specified - a case report and short literature review[J].Arch Clin Cases,2022,9(4):140-144. [4] Singh A,Bhagat M,Siddiqui AD,et al.Peripheral T-cell lymphoma,not otherwise specified:an unusual presentation of a rare lymphoma[J].other,2019,11(1):3813. [5] Shi L,Zeng Y,Lin H,Chen X.An atypical case of primary pulmonary peripheral T-cell lymphoma misdiagnosed as a pulmonary infectious disease:A case report and literature review[J].Indian Cancer,2021,58(2):302-306. [6] 蒋冲,来瑞鹤,滕月,等.基线18F-FDG PET/CT代谢参数及相关临床因素在非特指性外周T细胞淋巴瘤中的预后评估价值[J].中华核医学与分子影像杂志,2022,42(6):347-351. [7] 李毅,蔡瑞敏,王文洋,等.外周T细胞淋巴瘤非特指型的诊断学特征[J].中国实用医刊,2019,46(1):6-9. [8] Went,P.Marker expression in peripheral T-cell lymphoma:a proposed clinical-pathologic prognostic score[J].Journal of Clinical Oncology,2006,24(16):2472-2479. [9] 杨笋,张明智.CD30在外周T细胞淋巴瘤-非特指型中的表达与预后的相关研究[J].中国肿瘤临床,2019,46(10):485-489. [10] Xu P,Yu D,Wang L,et al.Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma,not otherwise specified:a single-institution study of 105 Chinese patients[J].Annals of Hematology,2015,94(2):239-247. [11] 赵维莅,蔡铭慈.我如何诊断和治疗外周T细胞淋巴瘤[J].中华血液学杂志,2019,40(5):363-367. [12] Qi F,Dong M,He X,et al.Gemcitabine,dexamethasone,and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified[J].Ann Hematol,2017,96(2):245-251. [13] 范潞艳,张伟华.程序性死亡受体1抑制剂治疗复发难治外周T细胞淋巴瘤-非特指型1例并文献复习[J].肿瘤研究与临床,2020,32(7):512-514.
2023, Vol. 29 
冀公网安备13080202000677号